Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 67-72 , May 2006

Overview of Non-Hodgkin’s Lymphoma

  • Barbara Barnes Rogers

      Affiliations

    • Corresponding Author InformationAddress correspondence to Barbara Barnes Rogers, CRNP, MN, AOCN®, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111

References 

  1. Reis L, Eisner M, Kosary C, et al (eds). SEER Cancer Statistics Review 1975-2002. National Cancer Institute. 2005. Available at: www.seer.cancer.gov (accessed September 20, 2005).
  2. Groves F , Linet M , Travis L , et al.   Cancer surveillance series (Non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995) . J Natl Cancer Inst . 2000;92:1240–1251
  3. Ramos-Casals M , DeVita S , Tzioufas AG . Hepatitis C Virus, Sjogren’s syndrome and B cell lymphoma (Linking infection, autoimmunity and cancer) . Autoimmune Rev . 2005;4:8–15
  4. Adami J , Gabel H , Lindelof B , et al.   Cancer risk following organ transplant (A nationwide cohort study in Sweden) . Br J Cancer . 2003;89:1221–1227
  5. Carbone A , Gloghini A . AIDS-related lymphoma (from pathogenesis to pathology) . Br J Haematol . 2005;10:1365–2141
  6. Fisher S , Fisher R . The epidemiology of non-Hodgkin’s lymphoma . Oncogene . 2004;23:6524–6534
  7. Stolte M , Bayerdorffer E , Morgner A , et al.   Helicobacter and gastric MALT lymphoma . Gut . 2002;50(suppl l3):11119–11124
  8. Ferreri A , Guidoboni M , Ponzoni M , et al.   Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas . J Natl Cancer Inst . 2004;96:586–594
  9. Hermine O , Lefrere F , Bronowicki J , et al.   Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection . N Engl J Med . 2002;347:89–94
  10. Kasamon YL , Swinnen LJ . Treatment advances in adult Burkitt’s lymphoma and leukemia . Curr Opin Oncol . 2004;16:429–435
  11. Ansell SM , Armitage J . Non-Hodgkin lymphoma (diagnosis and treatment) . Mayo Clin Proc . 2005;80:1087–1097
  12. Lascaux AS , Hemery F , Goujard C , et al.   Beneficial effects of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas . AIDS Res Hum Retroviruses . 2005;3:214–220
  13. Jaffe E , Harris N , Stein H . World Health Organization Classification of Tumours (Pathology and genetics of tumours of haematopoietic and lymphoid tissues) . Geneva, Switzerland: World Health Organization; 2001;
  14. Winter J , Gascoyne R , Van Besien K . Low grade lymphoma . Hematology (American Society of Hematology Education Program) . 2004;203–220
  15. Yarkoni S , Lishner M , Tangi I , et al.   B-cell non-Hodgkin’s lymphoma (evidence for the t(14;18) translocation in all hematopoietic cell lineages) . J Natl Cancer Inst . 1997;89:93–95
  16. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Non- Hodgkin’s Lymphoma. Jenkintown, PA; National Comprehensive Cancer Network; 2005; pp 1-62. Available at: Available at: www.nccn.org (accessed September 5, 2005).
  17. American Joint Committee on Cancer . In: AJCC Cancer Staging Handbook . Philadelphia, PA: Lippincott; 1998;p. 264
  18. Ganti AK , Bociek RG , Bierman PJ , et al.   Follicular lymphoma (expanding therapeutic options) . Oncology . 2005;19:213–228
  19. International Non-Hodgkin’s Lymphoma Prognostic Factor Project members . A predictive model for aggressive non-Hodgkin’s lymphoma-The International Non-Hodgkin’s Lymphoma Prognostic Factor Project . N Engl J Med . 1993;329:987–994
  20. Solal-Celigny P , Roy P , Colobmat P , et al.   Follicular lymphoma international prognostic index . Blood . 2004;104:1258–1265

PII: S0749-2081(06)00011-8

doi: 10.1016/j.soncn.2006.01.002

Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 67-72 , May 2006

Article Tools

* Image Usage & Resolution